Research
Researchers found that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early-stage prostate cancer treatment.
Latest stories
Individualized Medicine
November 6, 2024
Individualized Medicine
November 5, 2024
Health & Wellness
October 31, 2024
Cardiovascular
October 30, 2024
Individualized Medicine
October 30, 2024
Discovery Science
October 28, 2024
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community